+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Development of a novel formulation with hypericin to treat cutaneous leishmaniasis based on photodynamic therapy in in vitro and in vivo studies



Development of a novel formulation with hypericin to treat cutaneous leishmaniasis based on photodynamic therapy in in vitro and in vivo studies



Antimicrobial Agents and ChemoTherapy 59(9): 5804-5813



An evaluation of the leishmanicidal activity in vitro and in vivo of hypericin, an expanded-spectrum photosensitizer found in Hypericum perforatum, is presented. Hypericin was evaluated against intracellular amastigotes in vitro of Leishmania (Viannia) panamensis. A topical formulation containing 0.5% hypericin was developed and assayed in vivo in a hamster model of cutaneous leishmaniasis. Results demonstrate that hypericin induces a significant antiamastigote effect in vitro against L. panamensis by decreasing the number of parasites inside infected cells. The topical formulation of 0.5% hypericin allows healing of L. panamensis-induced lesions upon a topical application of 40 mg/day plus visible-light irradiation (5 J/cm(2), 15 min), twice a week for 3 weeks.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 057601399

Download citation: RISBibTeXText

PMID: 26169411

DOI: 10.1128/aac.00545-15


Related references

In-vitro and in-vivo studies on a topical formulation of sitamaquine dihydrochloride for cutaneous leishmaniasis. Journal of Pharmacy and Pharmacology 58(8): 1043-1054, 2006

Photodynamic therapy using methylene blue to treat cutaneous leishmaniasis. Photomedicine and Laser Surgery 29(10): 711-715, 2011

In vitro and in vivo evaluation of hypericin for photodynamic therapy of equine sarcoids. Veterinary Journal 159(1): 77-84, 2000

Hypericin and photodynamic therapy decreases human pancreatic cancer in vitro and in vivo. Journal of Surgical Research 93(1): 137-143, 2000

Antibiotic-free nanotherapeutics: hypericin nanoparticles thereof for improved in vitro and in vivo antimicrobial photodynamic therapy and wound healing. International Journal of Pharmaceutics 454(1): 249-258, 2013

A mechanistic study of delta-aminolevulinic acid-based photodynamic therapy for cutaneous leishmaniasis. Journal of Investigative Dermatology 127(6): 1546-1549, 2007

In vitro and in vivo studies of a chlorin-based carbon nanocarrier with photodynamic therapy features. Photochemical and Photobiological Sciences 17(10): 1329-1336, 2018

Response surface method optimization of a novel Hypericin formulation in P123 micelles for colorectal cancer and antimicrobial photodynamic therapy. Journal of Photochemistry and Photobiology. B Biology 170: 247-255, 2017

Parasiticidal effect of delta-aminolevulinic acid-based photodynamic therapy for cutaneous leishmaniasis is indirect and mediated through the killing of the host cells. Experimental Dermatology 16(8): 651-660, 2007

Cutaneous sporotrichosis treated with photodynamic therapy: an in vitro and in vivo study. Photomedicine and Laser Surgery 32(1): 54-57, 2014

In vitro and in vivo effects of photodynamic therapy in cutaneous T cell lymphoma. Acta Dermato-Venereologica 74(3): 201-205, 1994

In vitro and in vivo matrix metalloproteinase expression after photodynamic therapy with a liposomal formulation of aminolevulinic acid and its methyl ester. Cellular and Molecular Biology Letters 15(4): 630-650, 2010

Use of Optical Imaging Technology in the Validation of a New, Rapid, Cost-Effective Drug Screen as Part of a Tiered In Vivo Screening Paradigm for Development of Drugs To Treat Cutaneous Leishmaniasis. Antimicrobial Agents and ChemoTherapy 61(4):, 2017

Breast cancer resistance protein is the enemy of hypericin accumulation and toxicity of hypericin-mediated photodynamic therapy. Biomedicine and PharmacoTherapy 109: 2173-2181, 2019

Hypericin-loaded lipid nanocapsules for photodynamic cancer therapy in vitro. Nanoscale 5(21): 10562-10572, 2013